Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The heat-shock protein 70 chaperone machine is functionally connected to the ubiquitin-
proteasome
system by the co-chaperone CHIP. In this article, we discuss evidence that the neuronal DnaJ proteins HSJ1a and HSJ1b may represent a further link between the cellular protein folding and degradation machineries. We have demonstrated that
HSJ1
proteins contain putative ubiquitin interaction motifs and can modulate the cellular processing of rhodopsin, a protein that is targeted for degradation by the
proteasome
when it is misfolded.
...
PMID:Neuronal DnaJ proteins HSJ1a and HSJ1b: a role in linking the Hsp70 chaperone machine to the ubiquitin-proteasome system? 1527 Jun 96
Protein degradation in eukaryotic cells usually involves the attachment of a ubiquitin chain to a substrate protein and its subsequent sorting to the
proteasome
. Molecular mechanisms underlying the sorting process only recently began to emerge and rely on a cooperation of chaperone machineries and ubiquitin-chain recognition factors [1-3]. Here, we identify isoforms of the cochaperone
HSJ1
as neuronal shuttling factors for ubiquitylated proteins.
HSJ1
combines a J-domain that stimulates substrate loading onto the Hsc70 chaperone with ubiquitin interaction motifs (UIMs) involved in binding ubiquitylated chaperone clients.
HSJ1
prevents client aggregation, shields clients against chain trimming by ubiquitin hydrolases, and stimulates their sorting to the
proteasome
. In this way,
HSJ1
isoforms participate in ER-associated degradation (ERAD) and protect neurons against cytotoxic protein aggregation.
...
PMID:HSJ1 is a neuronal shuttling factor for the sorting of chaperone clients to the proteasome. 1593 78
HSJ1
(DNAJB2), a member of the DNAJ family of molecular chaperones, is a key player in neuronal proteostasis maintenance. It binds ubiquitylated proteins through its Ubiquitin Interacting Motifs (UIMs) and facilitates their delivery to the
proteasome
for degradation. Mutations in the DNAJB2 gene lead to inherited neuropathies such as Charcot-Marie-Tooth type-2, distal hereditary motor neuropathies, spinal muscular atrophy with parkinsonism and the later stages can resemble amyotrophic lateral sclerosis.
HSJ1
overexpression can reduce aggregation of neurodegeneration-associated proteins in vitro and in vivo; however, the regulation of
HSJ1
function is little understood. Here we show that CK2, a ubiquitous and constitutively active protein kinase, phosphorylates
HSJ1
within its second UIM, at the dominant site Ser250 and the hierarchical site Ser247. A phospho-
HSJ1
specific antibody confirmed phosphorylation of endogenous HSJ1a and HSJ1b. A tandem approach of phospho-site mutation and treatment with CK2 specific inhibitors demonstrated that phosphorylation at these sites is accompanied by a reduced ability of
HSJ1
to bind ubiquitylated clients and to exert its chaperone activity. Our results disclose a novel interplay between ubiquitin- and phosphorylation-dependent signalling, and represent the first report of a regulatory mechanism for UIM-dependent function. They also suggest that CK2 inhibitors could release the full neuroprotective potential of
HSJ1
, and deserve future interest as therapeutic strategies for neurodegenerative disease.
...
PMID:Protein kinase CK2 modulates HSJ1 function through phosphorylation of the UIM2 domain. 2803 Dec 92